Company / Capital Returned to Shareholders
Mettler Toledo Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$800.0M
FY2025
5-year range
$775.0M / $900.0M
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
#26 of 108
Health Care
What the data says
Mettler Toledo's capital returned to shareholders of $800M is higher than 76% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $400M in FY2019 to $900M in FY2023.
Based on SEC 10-K filings.
$800M in FY2025 with a 5-year CAGR of +11.0%. Top quartile in the Health Care sector.
Declined from $900M to $800M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -
Sector benchmark
+6.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.0%, indicating consistent growth.
- In FY2025, capital returned to shareholders decreased 5.9% year-over-year.
- Ranks #26 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $800.0M | -5.9% |
| FY2024 | $850.0M | -5.6% |
| FY2023 | $900.0M | +16.1% |
| FY2022 | $775.0M | -0.0% |
| FY2021 | $775.0M | +63.2% |
| FY2020 | $475.0M | +18.8% |
| FY2019 | $400.0M | -15.8% |
| FY2018 | $475.0M | +18.8% |
| FY2017 | $400.0M | -20.0% |
| FY2016 | $500.0M | +1.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026